Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow Fever Vaccine Immunity in HIV Infected Patients
NCT01426243Phase 3Completed
- Sponsor
- ANRS
- Start
- Jul 2011
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 3, open-label trial of 17D yellow fever vaccine in yellow fever (2 cohorts), sponsored by ANRS. Primary endpoints: Seroconversion by fluorescence, Cytotoxic response in ELISPOT and 3 more. Started Jul 2011; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT01426243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426243.